Latest news
EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop - TradingViewTradingView · Tue, 11 Aug 2026 11:07:00 GMTEmbecta Corp. 2026: Revenue $271.7M, EPS $0.36— 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 18:41:01 GMTEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 13:31:42 GMTEmbecta reports Q3 FY2026 revenue $271.7M, GAAP net income $21.1M; raises adjusted EPS guidance - TradingViewTradingView · Fri, 07 Aug 2026 11:13:01 GMTSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC - TradingViewTradingView · Thu, 06 Aug 2026 14:07:00 GMTLost Money on Embecta Corp. (EMBC)? Join Class Action Suit Seeking Recovery - Contact SueWallSt - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT